Netherlands· NL-90a1359ec746
Theranal aambeienzetpillen, zetpillen
A lidocaine product containing bismutsubnitraat + lidocaïne + zinkoxide, registered in Netherlands by Bayer B.V.. The same ATC class is registered in 10 of our 19 countries.
Checked against CBG-MEB (Netherlands) on
Informational only — not a medical device.
Where it is registered
Lidocaine is registered in 10 of 19 countries.
Countries holding a registration under ATC C05AD01 (lidocaine), each read from that country’s own register.
- This record: Netherlands, from CBG-MEB (Netherlands)
- 7 of them publish a price we can compare per daily dose
Lidocaine · ATC C05AD01
10 / 19 countries
- Belgiumprice
- Czechiaprice
- Denmark
- Finlandprice
- Germany
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Statesprice
The record
At a glance
CBG-MEB (Netherlands)- Active substance
- BISMUTSUBNITRAAT + LIDOCAÏNE + ZINKOXIDE
- Manufacturer
- Bayer B.V.
- Country
- Netherlands (NL)
- ATC code
- C05AD01
- ATC class
- Lidocaine
- Reimbursed
- Not published by this register
- Source register
- CBG-MEB (Netherlands)
- Last checked
- September 29, 2026
Packs & prices · 1
- cbg_meb_id01111
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
39 interactions on record for lidocaine.
Graded by severity as the source publishes them — 1 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Lidocaine · interactions on record
39 records
- 1 severe
- 38 moderate
Most severe, free to view
- PrilocaineN01BB04severe
- MetoclopramideA03FA01moderate
- SulfamethizoleB05CA04moderate
- Glyceryl trinitrateC01DA02moderate
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same class
Other records under C05AD01
Lidocaine, as other registers publish it.
- NorwayAntrolinNeopharmed Gentili
- CzechiaDOBEXIL H UNGBausch Health Ireland Limited, Dublin
- CzechiaDOBEXIL H UNGBausch Health Ireland Limited, Dublin
- SwitzerlandDoxiproct, pommade rectaleOM Pharma SA
- SwitzerlandDoxiproct, pommade rectaleOM Pharma SA
- United StatesDr. Care Numbing CreamShengnan (Guangzhou) Cosmetics Co., LTD
- United StatesGembooxt Topical Numbing CreamGuangdong Quadrant Ecological Technology Co., Ltd.
- United StatesGembooxt Topical Numbing CreamGuangdong Quadrant Ecological Technology Co., Ltd.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/71f02cb0-2ce5-4d54-b512-886046f758af GET /v1/drugs/71f02cb0-2ce5-4d54-b512-886046f758af?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Zetpil",
"route": "Rectaal gebruik",
"soort": "RVG",
"source": "cbg_meb",
"smpc_url": "https://www.geneesmiddeleninformatiebank.nl/smpc/h01111_smpc.pdf",
"strength": null,
"atc_label": "Lidocaine",
"detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/rvg01111",
"excipients": [
"ALCLOXA",
"ALUMINIUM-HYDROXY-N-ACETYL-DL-METHIONINE-ALLANTOINE (RI)",
"HARD VET"
],
"substances": [
"BISMUTSUBNITRAAT",
"LIDOCAÏNE",
"ZINKOXIDE"
],
"leaflet_url": "https://www.geneesmiddeleninformatiebank.nl/bijsluiters/h01111.pdf",
"authorised_at": "1973/10/24",
"procedure_number": null,
"dispensing_status": "Uitsluitend apotheek of drogist",
"registration_number": "01111",
"additional_monitoring": "N"
}See everything about lidocaine.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.